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Although patients with 
kidney disease may present 
with symptoms such as oedema (nephritic or 
nephrotic syndrome) and changes in urine 
composition, histological and functional renal 
decompensation can often not be diagnosed 
owing to a lack of symptoms. Undetected loss 
of kidney function over an extended period of 
time can eventually lead to the symptomatic 
stage of kidney failure or even end-stage 
renal disease. The only indication of the 
presence of renal disease in an asymptomatic 
patient may be a raised blood pressure with 
or without urine abnormalities detectable on 
urine examination, such as microalbuminuria 
and proteinuria cells, and casts on urine 
microscopy. 
General practitioners – not the nursing 
staff – should therefore perform urine 
dipstick tests for all their patients. Current 
trends where tests are not conducted by 
the examining medical professional but 
rather at a ‘test station’ should be dis-
couraged as consistency and expertise in 
the interpretation of the results are very 
important in the examination process. If 
blood or protein is detected, a fresh specimen 
should be centrifuged and examined under 
the microscope. 
General practitioners commonly mistake 
urine abnormalities for urinary tract 
infections and invariably refer patients to 
urologists. Factors that would necessitate 
referral to a nephrologist rather than a 
urologist are:
• degree of proteinuria – more protein, 
more likely glomerular disease
• presence of casts
• in addition, any of the following:
• kidney failure
• complicated hypertension
• serological activity on blood tests (e.g. 
erythrocyte sedimentation rate and 
antinuclear factor).
When a reduced glomerular filtration rate 
(GFR) is present, comorbidities should always 
be managed in their own right, e.g. anaemia, 
hyperkalaemia, metabolic disorders (i.e. 
calcium and phosphorus disorders) and – 
very important in the South African (SA) 
context – primary hypertension, which is the 
main cause of chronic kidney disease (CKD). 
The aetiology of CKD cannot always be 
easily determined and it is important to take 
a detailed history combined with a thorough 
clinical examination. It is often necessary to 
include examination of both structure (renal 
ultrasound) and function (estimated GFR 
(eGFR)) of the kidneys in the evaluation. 
CKD often presents as a urinary 
abnormality in the face of normal renal 
function. Detecting such patients early 
may protect renal function and delay the 
need for dialysis by treating the underlying 
disease, reducing hyperfiltration and 
treating comorbidities. A complication of 
CKD is that patients have a higher risk 
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Any patient seeking any form of medical advice at any clinic or hospital, or from a doctor or other healthcare worker, should have their 
blood pressure recorded and a urine dipstick test done. The most useful indication of a diagnosis of any stage of chronic kidney disease, is 
the presence of either hypertension, urinary dipstick abnormality or both. Many practitioners frequently refer such patients to urologists, 
which must be discouraged. Referral should be to a nephrologist or specialist physician. 



















Fig. 1. Clinical course of chronic kidney disease (CKD). CKD progresses from stage 1 to stage 5. More 
patients may die of cardiovascular diseases than progress to a higher stage of CKD. (MI = myocardial 
infarction; CHF = congestive heart failure; GFR = glomerular filtration rate; DM = diabetes mellitus.)
CONTINUING MEDICAL EDUCATION
       March 2015, Vol. 105, No. 3
of developing cardiovasvular disorders 
(CVDs), e.g. stroke, acute myocardial 
infarction (MI) and congestive heart failure 
(CHF). This risk increases exponentially as 
CKD progresses towards end-stage kidney 
disease and patients sometimes die of this 
complication before they reach the final 
stage of CKD, when renal replacement 
therapy is required. This is indicated by 
wider arrows in Fig. 1.[1] 
The diagnosis of CKD is often accompanied 
by (i) microalbuminuria (earliest abnormality) 
or (ii) proteinuria on the urine dipstick test, 
even before any significant reduction in 
kidney function can be detected.
It may happen that CKD is only diagnosed 
when a complication such as anaemia or 
a bone mineral disorder occurs. These 
complications are more frequently found in 
stages 4 and 5 CKD, when kidney function 
is significantly reduced. This again shows 
the importance of early diagnosis in order to 
limit or prevent such complications.
Unfortunately, a large group of public 
sector patients in SA are referred to renal 
units for the first time when they present 
with end-stage renal failure (ESRF). This 
may be the result of insufficient access 
to adequate healthcare facilities and no 
regular follow-up visits, especially when 
abnormalities are detected in the earlier 
stages of CKD. Patients are often admitted 
for acute kidney failure, which could have 
been prevented with regular checkups.
Kidney disease as a result of drug toxicity is 
not always associated with urine dipstick test 
abnormalities. Furthermore, there may not be 
any evidence of previous risk factors for CKD. 
When prescribing drugs that are excreted 
via the kidney or that are nephrotoxic, one 
should evaluate and regularly monitor the 
eGFR. 
Importantly, patients >45 years of age lose 
GFR by 1 mL/min/year, even though  they may 
present with a ‘normal’ serum creatinine level. 
Consequently, many elderly people fall into 
stage 3 CKD (<60 mL/min/1.73 m2), despite an 
apparent normal creatinine level.
CKD and CVD: 
Cardiorenal association
The classic target organs in CVD (heart, 
brain and kidneys) may be associated 
with CKD. Specifically, patients with CKD 
(especially those on dialysis) often have 
a combination of chronic inflammation 
and chronic malnourishment that may 
contribute to the pathogenesis of accelerated 
atherosclerosis.
CKD and CVD share many common risk 
factors, which is evident in the increased 
morbidity and mortality rates for stroke, MI 
and CHF. It is therefore very important to 
establish the possible relationship between 
CKD and CVD for any patient with early 
signs of CVD.
Statistics show that CKD patients are 
more at risk of dying from CVD than ESRF. 
This is highlighted in Fig. 2,[2] where CVD-
related deaths and renal-related deaths in 
the US population are compared according 
to CKD function levels. In the earlier stages 
of CKD and even in the progressive stage 4 
of CKD, patients are more likely to die from 
CVD than renal failure. Deaths from CVD in 
patients with proteinuria are more common 
than in those without proteinuria.   
It has been reported in Europe, the USA 
and Japan that even a mild reduction in 
kidney function (stages 1 and 2) and/or the 
presence of proteinuria increases the risk of 
MI and stroke.
It has, however, also been shown that kidney 
function is affected by CVD. In this regard 
the data from Anavekar et al.[3] show that 
one-third of patients who suffered from MI 
had kidney function related to stage 3 CKD 
(eGFR <60 mL/min/1.73 m2) (Fig. 3).
From the same study[3] the follow-up of 
MI sufferers within 3 years after the first 
attack showed that there is a correlation 
between increased risk of reinfarction and 
advanced stages of CKD. This can be seen 
in Fig. 4.
Common risk factors preceding either 
CKD, CVD or both include endothelial 
damage caused by fluid retention and 
hypervolaemia. Anaemia is a risk factor for 
the development of CVD. In patients with 
stages 3b - 5 CKD, anaemia is a risk factor 
in hastening progression to ESRF. Therefore, 
anaemia should be treated accordingly. In 
Fig. 2. Comparison of the rate of death prior to transplant/dialysis and renal replacement therapy. Data, 
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Fig. 3. Distribution of estimated glomerular filtration rate at baseline among 14 527 patients. Data, with 
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VALIANT study: N=14 527. GFR<60 mL/min/1.73 m2 was 4 862 (33.5%)
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addition, the following factors affect the 
function and structure of the kidneys 
and heart vasculabia: hypertension, 
calcium, phosphate and parathyroid 
hormone abnormalities, inflammation, 
increased sympathetic tone, disturbances 
in the renin-angiotensin-aldosterone axis, 
oxidative stress, dyslipidaemia, smoking 
and an increase in the levels of asymmetric 
dimethylarginine. 
NB: A recent and very important study 
was done on the role of increased plasma 
levels of trimethylamine N-oxide (TMAO) 
in CKD, which is also associated with 
coronary artery disease pathogenesis. This 
study found that a gut microbial-dependent 
metabolite of dietary choline, lecithin 
(phosphatidylcholine) and L-carnitine 
occur early in patients with CKD. These 
serum levels increase with the severity of 
CKD. TMAO was found to cause more 
rapid renal functional deterioration, vascular 
endothelial damage, renal fibrosis, atheroma 
and CVD. These dietary amino acids are 
especially high in all red meats (including 
pork), but not in poultry or most fish. 
Consequently, it might in future become 
advisable to place our earlier CKD patients 
(e.g. those with stages 3a or 3b CKD) on 




Generally, lifestyle-related disease (LRD) 
is defined as a disorder affected by and 
normally related to aspects of diet and 
lifestyle. As communities progress from 
hunter gatherers/subsistence farmers, 
where food was less readily available and 
required physical effort to obtain, to a 
more affluent lifestyle with less exercise 
and ‘fast food’, this problem has increased 
worldwide. SA is no exception, and in 
future the impact on healthcare is expected 
to increase. 
It needs to be acknowledged that there 
is also a genetic factor to LRDs, but the 
most common complications of metabolic 
syndrome (excessive or non-balanced 
eating and lack of exercise or movement, 
which causes fat accumulation even to the 
extent of morbid obesity) are hypertension, 
diabetes and dyslipidaemia. The similarities 
between insulin resistance (pre-diabetes) 
and metabolic syndrome often result in the 
interchangeability of the two terms, with the 
only distinction related to the symptomatic 
presentation for diagnosis. Table 1 provides 
a guideline for the diagnosis of metabolic 
syndrome.
The direct relationship between contri-
buting factors of LRDs (e.g. smoking, lack of 
exercise and stress) and CKD has been well 
researched and can be caused by abdominal 
obesity accumulating in visceral fat, which 
may cause proteinuria or reduced kidney 
function. It is therefore of vital importance 
that early diagnosis of CKD should 
trigger changes in lifestyle and diet for the 
management and prevention of progression 
of CKD. This is even more important in 
the SA context, where healthcare is greatly 
affected by limited resources and funding. 
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Table 1. WHO clinical criteria for metabolic syndrome* 
Insulin resistance, identified by one of the following:
• Type 2 diabetes
• Impaired fasting glucose
• Impaired glucose tolerance
• Or, for those with normal fasting glucose levels (<110 mg/dL), glucose uptake below the 
lowest quartile for background population under investigation under hyperinsulinaemic, 
euglycaemic conditions 
Plus any two of the following:
• Antihypertensive medication and/or high blood pressure (≥140 mmHg systolic or 
≥90 mmHg diastolic)
• Plasma triglycerides ≥150 mg/dL (≥1.7 mmol/L)
• High-density lipoprotein cholesterol <35 mg/dL (<0.9 mmol/L) in men, or <39 mg/dL 
(1.0 mmol/L) in women
• BMI >30 kg/m2 and/or waist:hip ratio >0.9 in men, or >0.85 in women 
• Urinary albumin
BMI = body mass index.
*Derived from Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: 
Diagnosis and classification of diabetes mellitus: Provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
Fig. 4. Kaplan-Meier estimates of the rates of death at 3 years from cardiovascular disease causes reinfarction, 
congestive heart failure, stroke, resuscitation after cardiac arrest, and the composite endpoint, according to the 





















CHF Stroke Resuscitation Composite
endpoint
GFR: ≥75.0 mL/min/1.73 m2 
GFR: 60.0 - 74.9 mL/min/1.73 m2 
GFR: 45.0 - 59.9 mL/min/1.73 m2 
GFR: <45.0 mL/min/1.73 m2 
VALIANT study: Acute myocardial infarction (N=14 527)
